2020
DOI: 10.1002/ccr3.3539
|View full text |Cite
|
Sign up to set email alerts
|

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Abstract: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
0
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 14 publications
0
0
0
Order By: Relevance
“…According to the literature, the incidence of amiodarone-induced TdP is less than 1% [ 11 ], and it increases with IV administration [ 12 ]. TdP usually occurs within 24 hours after initiation of the IV therapy [ 12 ], but it can happen even three days after amiodarone infusion [ 11 ]. However, it is extremely rare for short-time administration of amiodarone to cause LQTS and TdP [ 11 - 13 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…According to the literature, the incidence of amiodarone-induced TdP is less than 1% [ 11 ], and it increases with IV administration [ 12 ]. TdP usually occurs within 24 hours after initiation of the IV therapy [ 12 ], but it can happen even three days after amiodarone infusion [ 11 ]. However, it is extremely rare for short-time administration of amiodarone to cause LQTS and TdP [ 11 - 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…TdP usually occurs within 24 hours after initiation of the IV therapy [ 12 ], but it can happen even three days after amiodarone infusion [ 11 ]. However, it is extremely rare for short-time administration of amiodarone to cause LQTS and TdP [ 11 - 13 ]. The risk factors for malignant arrhythmias in amiodarone-induced LQTS are rapid amiodarone administration, renal failure, acute myocardial infarction, heart failure, hypokalemia, hypomagnesemia, genetic predisposition, bradycardia, QTc interval >500 ms and/or QTc interval increase by ≥60 ms from the baseline value [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…It acts mainly by blocking the potassium channels, resulting in the prolongation of myocardial repolarization, represented by prolongation of the QT interval, particularly in the setting of predisposing conditions such as left ventricular hypertrophy, bradycardia, hypokalemia, and hypomagnesemia [2,3]. Although rare, amiodarone-induced polymorphic ventricular tachycardia is a potentially fatal complication [1][2][3][4][7][8][9]. Therefore, we hypothesized that the use of intravenous amiodarone and the presence of multiple precipitating risk factors (e.g., hypokalaemia and hypomagnesemia) put our patient at increased risk of developing prolonged QT and, subsequently, potentially life-threatening arrhythmic storm.…”
Section: Discussionmentioning
confidence: 99%